转出过渡护理对重症加强护理病房重症慢性阻塞性肺疾病患者的影响被引量：3

导出

摘要目的观察转出过渡护理对重症加强护理病房(ICU)重症慢性阻塞性肺疾病(COPD)患者的临床症状、重返ICU发生率及护理满意度的影响。方法选取福建医科大学附属第一医院2016年1月—2016年12月66例从ICU病房转出至呼吸内科病房的重症COPD患者,按照时间顺序分为对照组和观察组,每组33例。对照组予以基础护理,观察组成立转出过渡护理小组,对患者进行科学的护理,两组护理1周后比较临床症状、重返ICU发生率及护理满意度。结果与对照组护理后比较,观察组呼吸顺畅、动脉血氧分压(Pa O2)、血氧饱和度(Sp O2)改善明显(P<0.05),重返ICU的发生率(3.03%)低于对照组(P<0.05),且患者对医护人员的护理满意度(93.94%)明显高于对照组(P<0.05)。结论转出过渡护理对ICU重症患者的临床症状有所改善,重返ICU的发生率降低,对护理人员的满意度提高。

作者罗金燕林婕

机构地区福建医科大学附属第一医院

出处《慢性病学杂志》 2017年第9期1007-1009,共3页 Chronic Pathematology Journal

关键词慢性阻塞性肺疾病过渡期护理重症监护病房

分类号 R473.5 [医药卫生—护理学]

引文网络
相关文献

参考文献1

1宋琳,韩锋锋.2016年版GOLD慢性阻塞性肺疾病全球倡议解读[J].世界临床药物,2016,37(7):437-440. 被引量：45

二级参考文献12

1Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBIAVHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J]. Am J Respir Crit Care Med 2001, 163 (5) : 1256-1276.
2Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). updated 2016. http://goldcopd.org/.
3Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). updated 2015. http://goldcopd.org/.
4Puteha N, Drummond MB, Connett JE, et al. Chronic productive cough is associated with death in smokers with early COPD [J]. COPD, 2014, 11 (4) : 451-458.
5Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects [J]. Chest, 2009, 135 (4) : 975-982.
6Rossi A, Guerriero M, Corrado A, et al. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO) [J]. Respir Res, 2014, 15 (1) : 77-77.
7Dransfield MT, Feldman G, Korenblat P, et al. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients[J]. Respir Med, 2014, 108(8): 1171-1179.
8Yu T, Fain K, Boyd CM, et al. Benefits and harms of roflumilast in moderate to severe COPD EJ. Thorax, 2014, 69(7): 616-622.
9Kon SS, Dilaver D, Mittal M, et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference[J]. Thorax, 2014, 69 (9) : 793-798.
10Busch AM, Scott-Sheldon LA, Pierce J, et al. Depressed mood predicts pulmonary rehabilitation completion among women, but not men[J]. Respir Med, 2014, 108 (7) : 1007-1013.